mRNA |
cediranib |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.8 |
mRNA |
avicin D |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.8 |
mRNA |
neratinib |
CTRPv2 |
pan-cancer |
AAC |
-0.01 |
0.8 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.01 |
0.8 |
mRNA |
BRD-K61166597 |
CTRPv2 |
pan-cancer |
AAC |
0.0092 |
0.8 |
mRNA |
MK 1775 |
CTRPv2 |
pan-cancer |
AAC |
-0.0098 |
0.8 |
mRNA |
TPCA-1 |
GDSC1000 |
pan-cancer |
AAC |
-0.0083 |
0.8 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0084 |
0.8 |
mRNA |
ML210 |
CTRPv2 |
pan-cancer |
AAC |
-0.0093 |
0.8 |
mRNA |
FGIN-1-27 |
CTRPv2 |
pan-cancer |
AAC |
0.021 |
0.8 |